A federal judge has declined to toss out a lawsuit in which Aetna alleged the maker of a highly addictive opioid-based painkiller duped the insurance company into paying reimbursements for off-label uses.

In an Aug. 23 ruling, U.S. District Judge Cynthia Rufe of the Eastern District of Pennsylvania denied defendant Insys Therapeutic’s request to dismiss the case.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]